MARKET

MRK

MRK

Merck & Co
NYSE
117.15
-0.50
-0.43%
After Hours: 116.60 -0.55 -0.47% 19:57 02/10 EST
OPEN
117.69
PREV CLOSE
117.65
HIGH
118.18
LOW
116.10
VOLUME
11.85M
TURNOVER
--
52 WEEK HIGH
122.66
52 WEEK LOW
71.26
MARKET CAP
290.77B
P/E (TTM)
16.09
1D
5D
1M
3M
1Y
5Y
1D
Top Merck Executive Makes Major Move With Multi-Million-Dollar Stock Sale
TipRanks · 7h ago
Merck's Keytruda gains additional indications for ovarian, fallopian tube carcinoma
Seeking Alpha · 10h ago
FDA approves Merck’s Keytruda, Keytruda Qlex for platinum-resistant carcinomas
TipRanks · 12h ago
Merck Broadens Growth Drivers With Women’s Health And Infant RSV Moves
Simply Wall St · 13h ago
3 Best ETFs to Invest In, According to AI Analyst, 02/10/2026
TipRanks · 16h ago
SA analyst upgrades/downgrades: TSLA, MRK, CRWD, STLA
Seeking Alpha · 17h ago
Gilead Sciences: Buy This Stock For Both Dividend And Growth
Seeking Alpha · 22h ago
Stock Market Today, Feb. 9: Oracle Climbs on AI Optimism Despite Software Sector Weakness
The Motley Fool · 1d ago
More
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.